The number of events was 668 in the placebo group compared with 579 in the oral semaglutide group, supporting a consistent CV benefit (60)
250 mg or 500 mg twice daily with meals) and gradually increased over several weeks to a target dose of 2,000 mg daily
Lixisenatide (ADLYXIN) Phonetic pronunciation: LIX i SEN a tide / ad LIX in Mnemonic: Add licks in a Tide (Pod) Year of release: 2016 Price range: $690$710 FDA-approved for: Type 2 diabetes Mechanism: GLP-1 receptor agonist Available doses: 10 mcg, 20 mcg Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none in a bubble Lixisenatide (Adlyxin) is the newer exendin-based GLP analog
In addition, and in accordance with national law, marketing authorisation holders of GLP-1 receptor agonists will need to ensure that the messages they use to promote these medicines have been approved by regulatory authorities
Anecdotal reports suggest it is a potent anabolic but even amongst the IPED community, it appears there is some confusion over-dosing schedules and effects (Llewellyn, 2017)
